Westpac Banking Corp trimmed its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 88.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,724 shares of the company’s stock after selling 37,000 shares during the quarter. Westpac Banking Corp’s holdings in Henry Schein were worth $865,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Bluestein R H & Co. grew its stake in Henry Schein by 22.5% in the first quarter. Bluestein R H & Co. now owns 123,224 shares of the company’s stock valued at $20,944,000 after purchasing an additional 22,608 shares in the last quarter. BlackRock Inc. grew its stake in Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after purchasing an additional 5,414,761 shares in the last quarter. Azimuth Capital Management LLC grew its stake in Henry Schein by 4.9% in the first quarter. Azimuth Capital Management LLC now owns 36,234 shares of the company’s stock valued at $6,159,000 after purchasing an additional 1,705 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Henry Schein by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 310,134 shares of the company’s stock valued at $52,714,000 after purchasing an additional 1,831 shares in the last quarter. Finally, Aviva PLC grew its stake in Henry Schein by 0.5% in the second quarter. Aviva PLC now owns 50,249 shares of the company’s stock valued at $9,195,000 after purchasing an additional 230 shares in the last quarter. Hedge funds and other institutional investors own 89.11% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at 175.34 on Monday. The company has a market capitalization of $13.86 billion, a P/E ratio of 25.62 and a beta of 1.10. The company has a 50-day moving average price of $174.96 and a 200 day moving average price of $176.25. Henry Schein, Inc. has a 1-year low of $146.23 and a 1-year high of $186.99. Henry Schein’s stock is going to split on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be issued to shareholders after the market closes on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same period in the prior year, the company earned $1.64 earnings per share. Henry Schein’s revenue was up 6.4% compared to the same quarter last year. Equities research analysts anticipate that Henry Schein, Inc. will post $7.27 EPS for the current year.
A number of research analysts have weighed in on the company. Credit Suisse Group restated a “hold” rating and issued a $175.00 price target on shares of Henry Schein in a research note on Tuesday, August 29th. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 target price for the company in a research note on Monday, August 7th. BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $177.00 target price on shares of Henry Schein in a research note on Friday, July 21st. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the stock. Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $186.50.
TRADEMARK VIOLATION WARNING: This story was posted by Markets Daily and is owned by of Markets Daily. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.themarketsdaily.com/2017/09/11/westpac-banking-corp-has-865000-holdings-in-henry-schein-inc-hsic.html.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.27% of the stock is currently owned by corporate insiders.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.